Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
age associated memory impairment
aggression
agitation
algorithm
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early symptoms
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, prognosis of
Alzheimer's disease, risk factors in
Alzheimer's disease, telling patient diagnosis of
Alzheimer's disease, treatment of
amyloid beta protein
anosognosia
anticholinesterase
anticoagulant, treatment
antidepressant
antiphospholipid antibodies
anxiety
atypical
behavior
behavior, combative
behavioral disorder
biologic markers
carbamazepine
caregiver
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
children
complications
controversies in neurology
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, diagnostic evaluation of
dementia, driving with
dementia, early detection
dementia, preexisting in stroke patient
dementia, screening for
dementia, treatment of
donepezil
driving
driving restrictions
driving test
dural sinus thrombosis
dying
efficacy
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
gadolinium
galantamine
headache
hydrocephalus
incidence
intellectual deficit
intracranial pressure, increased
level of consciousness, decreased
medical-legal aspects of neurology
memory
memory, impairment of
memory, impairment of, subjective
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
Mini Mental Status Examination
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, venography
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic examination, focal
neurologic symptoms
olanzapine
old age, driving and
old age, neurology of
oral contraceptives
patient information and support
pitfalls
practice guidelines
preclinical
pregnancy, neurologic complications in
prethrombotic state
prognosis
protein C deficiency
protein S deficiency
psychological testing
psychosis
psychotic behavior
quetiapine
review article
risk factors
risk factors, modification
risperidone
rivastigmine
safety
seizure
selective serotonin reuptake inhibitors
suicide
tissue plasminogen activator, intravenous
treatment of neurologic disorder
white matter disease
workup
Showing articles 650 to 700 of 1454 << Previous Next >>

Natural History of Mild Cognitive Impairment in Older Persons
Neurol 59:198-205, Bennett,D.A.,et al, 2002

Response of Intra-Arterial and Combined Intravenous and Intra-Arterial Thrombolytic Therapy in Patients with Distal Internal Carotid Artery Occlusion
Stroke 33:1821-1826,1827, Zaidat,O.O,et al, 2002

Splinting vs Surgery in the Treatment of Carpal Tunnel Syndrome, A Randomized Controlled Trial
JAMA 288:1245-1251, Gerritsen,A.A.M.,et al, 2002

Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke
Stroke 33:22236-2242, Gilligan,A.K.,et al, 2002

Arterial Reocclusion in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
Neurol 59:862-867, Alexandrov,A.V. &Grotta,J.C., 2002

Tinnitus
NEJM 347:904-910, Lockwood,A.H.,et al, 2002

Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Stroke 33;2506-2508, Wein,T.H.,et al, 2002

Thrombolysis for Acute Stroke in Routine Clinical Practice
Arch Int Med 162:1994-2001, Bravata,D.M.,et al, 2002

Clinicopath Conf., Adenocarcinoma with Metastasis to Liver, with Hypercoagulable State Resulting in Thrombophlebitis & Nonbacterial Thrombotic Endocarditis, with Multiple Embolic Infarcts (Trousseau's
NEJM 347:1187-1194, Case 31-2002, 2002

Potentially Reversible Conditions in 1000 Consecutive Memory Clinic Patients
JNNP 73:390-394, Hejl,A.,et al, 2002

Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002

Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002

Prognosis for Gross Motor Function in Cerebral Palsy
JAMA 288:1357-1363,1399, Rosenbaum,P.L., et al, 2002

Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women
JAMA 288:2123-2129,2170, Zandi,P.P.,et al, 2002

Incidental Findings on Pediatric MR Images of the Brain
AJNR 23:1674-1677, Kim,B.S.,et al, 2002

Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
Ann Int Med 137:840-849, Snow,V.,et al, 2002

Late Secondary Ischemic Injury in Patients Receiving Intraarterial Thrombolysis
Ann Neurol 52:698-703,695, Kidwell,C.S.,et al, 2002

The Internet
JNNP 73:619-628, Al-Shahi,R.,et al, 2002

Incidence and Outcome of Mild Cognitive Impairment in a Population-Based Prospective Cohort
Neurol 59;1594-1599, Larrieu,S.,et al, 2002

Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke
Stroke 33:2866-2870, Lisboa,R.C.,et al, 2002

Mild Cognitive Impairment in Older People
Lancet 360:1963-1965, Burns,A., &Zaudig,M., 2002

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
NEJM 345:1515-1521,1567, in 'T Veld,B.A.,et al, 2001

Current Concepts in Mild Cognitive Impairment
Arch Neurol 58:1985-1992, Petersen,R.C.,et al, 2001

Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke
JAMA 286:2830-2838, Patel,S.C.,et al, 2001

Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke
Arch Neurol 58:2009-2013, Grotta,J.C.,et al, 2001

Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001

Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001

Influence of Leisure Activity on the Incidence of Alzheimer's Disease
Neurol 57:2236-2242, Scarmeas,N.,et al, 2001

CSF Detection of the 14-3-3 Protein in Unselected Patients with Dementia
Neurol 56:1528-1533, Burkhard,P.R.,et al, 2001

Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001

Stem-Cell Research: Drawing the Line
Lancet 358:163,217, Greenberg,D.S., 2001

Drugs for Alzheimer's Disease
BMJ 323:123-124, O'Brien,J.T . &Ballard,C.G., 2001

Galantamine (Reminyl) for Alzheimer's Disease
Medical Letter 43:53-54, , 2001

High-Dose Estradiol Improves Cognition for Women with AD, Results of a Randomized Study
Neurol 57:605-612, Asthana,S.,et al, 2001

A 24-Week, Randomized, Double-Blind Study of Donepezil in Moderate to Severe Alzheimer's Disease
Neurol 57:613-620, Feldman,H.,et al, 2001

Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001

Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001

Parenchymal Hyperdensity on Computed tomography after Intra-Arterial Reperfusion Therapy for Acugte Middle Cerebral Artery Occlusion,Incidence and Clinical Significance
Stroke 32:2042-2048, Nakano,S.,et al, 2001

Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001

Cerebral Hemorrhage After Intra-arterial Thrombolysis for Ischemic Stroke
Neurol 57:1603-1610, Kase,C.S.,et al, 2001

Carotid Endarterectomy
The Neurologist 7:135-136, Stewart-Amidei,C., 2001

Most Commonly Asked Questions About Intra-arterial Thrombolysis
The Neurologist 7:127-131, Wechsler,L.R., 2001

Practice Parameter: Diagnosis of Dementia (an Evidence-Based Review)
Neurol 56:1143-1153, Knopman,D.S.,et al, 2001

Practice Parameter: Management of Dementia (an Evidence-Based Review)
Neurol 56:1154-1166, Doody,R.S.,et al, 2001

Intraspinal Steroids: History, Efficacy, Accidentality, and Controversy with Review of United States Food and Drug Administration Reports
JNNP 70:433-443, Nelson,D.A. & Landau,W.M., 2001

A Reevaluation of the Duration of Survival After the Onset of Dementia
NEJM 344:1111-1116, Wolfson,C.,et al, 2001

Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001

Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001

How Neurologists Can Enhance Patient-Centered Medicine
Neurol 56:144-145, Berant,J.L., 2001

A Messy Necessary End
Neurol 56:148-152, Goldblatt,D., 2001



Showing articles 650 to 700 of 1454 << Previous Next >>